Some studies promote the inhibitory roles of TIM-3 in suppressing effector Th1/Tc1 responses [14,58]; therefore, TIM-3 could have beneficial anti-inflammatory role in the CRC TME. Here, HAVCR2 is linked to colorectal carcinoma.